The Jupyter notebook system gives Python users a visual, interactive way to run code, display the results, and share the source with others. But Jupyter notebooks have limited interactivity ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could ...